Advertisement

Topics

Companies Related to "Pituitary ACTH Hypersecretion Cushing Disease Pipeline Review 2018" [Most Relevant Company Matches] [Advanced Search Results] RSS

08:55 EDT 23rd October 2018 | BioPortfolio

Here are the most relevant search results for "Pituitary ACTH Hypersecretion Cushing Disease Pipeline Review 2018" found in our extensive corporate database of over 50,000 company records.

Showing "Pituitary ACTH Hypersecretion Cushing Disease Pipeline Review 2018" Companies 1–25 of 3,500+

Relevant

Expert Opinion

The Expert Opinion series of review journals provides systematic and authoritative analysis to support every stage in the pharmaceutical pipeline. Our expertly crafted review articles enable the R&D community to access and track the key advances that lead to the creation of new drugs.


Diabetes & Glandular Disease Clinic of San Antonio

The Diabetes & Glandular Disease Clinic, P.A. (DGD) offers the best in treatment for hormonal and metabolic disorders such as type 1 and 2 diabetes, gestational diabetes, thyroid disease, osteoporosis, lipid disorders (high cholesterol), pituitary/adrenal gland problems, menstrual disorders and hirsutism (excessive facial hair on women). All our doctors are board-certified in Endocrinology & Metab...

Strongbridge Biopharma plc

Following the successful completion of its exchange offer to acquire the issued ordinary shares of Cortendo AB, Strongbridge Biopharma is now the new parent company of the Cortendo group. The group’s strategic focus is to build a biopharmaceutical company focused on the development, in-licensing, acquisition and eventual commercialization of complemen...


Landos Biopharma, Inc.

Landos Biopharma, Inc. is an emerging biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune diseases. Landos’ lead clinical asset, BT-11, is a novel, locally-acting small molecule targeting inflammatory bowel disease (IBD) that is expected to enter clinical testing for Crohn’s...

Informa Healthcare - Expert Opinion series

The Expert Opinion series of review journals provides systematic and authoritative analysis to support every stage in the pharmaceutical pipeline. Our expertly crafted review articles enable the R&D community to access and track the key advances that lead to the creation of new drugs

Alpha Review Corporation

Alpha Review Corporation (ARC) was formed in 1995 as a medical bill review company. ARC customizes its bill review services to meet the client's individual needs by setting specific and unique customer notification parameters, providing customized management reports, and meeting any number of perhaps seemingly minor, but critical needs. This ensures a smoo...

Harvard Business Review

Harvard Business Review is the leading destination for smart management thinking. Through its flagship magazine, 12 international licensed editions, books from Harvard Business Review Press, and digital content and tools published on HBR.org, Harvard Business Review provides professionals around the world with rigorous insights and best practic...

Technology Review

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review’s media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website Techno...

Technology Review, Inc.

Technology Review, Inc., an independent media company owned by MIT, is the authority on the future of technology, identifying emerging technologies and analyzing their impact for leaders. Technology Review’s media properties include Technology Review magazine, the oldest technology magazine in the world (founded in 1899); the daily news website Techno...

Curaxis Pharmaceutical Corp

Curaxis is an emerging specialty pharmaceutical company with a hormone drug product candidate for the treatment of Alzheimer's disease and multiple cancers. Curaxis' therapeutic platform is based on the hypothesis that many diseases of aging may be caused by age-related changes in the function of the hypothalamic-pituitary-gonadal (HPG) axis. The HPG axis is a hormonal endocrine feedback loop that...

PureTech Health

PureTech Health (PureTech Health plc, PRTC.L) is a cross-disciplinary healthcare company, developing innovative products that could improve the lives of billions of patients. PureTech has a pipeline of 12 operating companies, seven of which are "growth stage" with external validation including strategic partnerships, outside funding, proof-of-concep...

MDReview

MDReview provides highly effective and innovative physician peer review, delivered with the utmost integrity. MDReview’s main purpose is to support hospitals in making some of the most important decisions that are at the heart of their quality management efforts. With a national reach to a diverse client base in all 50 state, MDReview is the standard ...

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases. Neuraltus has three clinical-stage programs in its development pipeline, including potential treatments for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's...

Advarra

Advarra, headquartered in Columbia, MD, provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. Its robust regulatory expertise and innovative technology ensure the highest standards of research ...

EPIXMedical Incorporated

EPIX's goal is to transform the management and diagnosis of vascular disease through the development of targeted MRI contrast agents. Based on its core, proprietary technology, EPIX is advancing its pipeline of products such as MS-325, the Company's lead MRI contrast agent currently in Phase III trials. MS-325 is also in development to help diagnose coronary artery disease, breast cancer, female s...

Proximagen Neuroscience plc

Proximagen Neuroscience plc is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease. Proximagen is building a compound pipeline to address the significant unmet medical needs of patients with neurodegenerative disease through its own discovery programme for novel, low risk therapeutic can...

Chesapeake IRB

Chesapeake IRB, an AAHRPP-accredited company, provides independent IRB submission and review services to pharmaceutical, biotech and medical device companies, as well as academic medical centers and hospital systems. Its paperless, cloud-based submission and review platform, CIRBI, leads the field and has set the standard in review turnaround time, quality...

Quorum Review

Welcome to Quorum Review Our mission is to safeguard the rights and well-being of research participants while enhancing the clinical research process.

Charities Review Council

The Charities Review Council's mission is to mobilize informed donors and accountable nonprofits to advance the greater good. The Council is an independent resource for people who support charities with financial donations. It is dedicated to empowering donors in making informed and thoughtful giving decisions, so that they can be more effective in helping charities advance their important commu...

BZresources

BZresources regularly manages high volume, complex, Electronically Stored Information (ESI) intensive cases. In each case, we identify, test and implement the most cost effective tools and then customize our processes to reduce review, production and eventual trial costs. Our solutions have been used during BartkoZankel’s cases. We offer clients these...

Vancouver Pharmacy Institute

VPI offers an intensive 16-week pharmacy review program designed to help prepare foreign-educated pharmacists achieve licensing in Canada:A five-module program tailored to meet the requirements of the Pharmacy Examining Board of Canada (PEBC®) evaluating exam and part of the qualifying exam.Faculty of highly experienced pharmaceutical scientists and professional pharmacists.Indepth review of key ...

Nuvelo, Inc.

Nuvelo, Inc. is dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular disease, cancer and other debilitating medical conditions. Nuvelo's development pipeline includes NU172, a direct thrombin inhibitor in Phase 1 development for use as a potential short-acting anticoagulant during medical or surgical proce...

CuraGen

CuraGen Corporation (Nasdaq: CRGN) is a biopharmaceutical company dedicated to improving the lives of patients by developing novel pharmaceutical products that address unmet medical needs. CuraGen’s deep understanding of the human genome has enabled us to gain greater insight into the molecular basis of disease. The Company's therapeutics are based on novel drug targets that are believed to pl...

uBiome, Inc.

Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome’s commercial products include SmartGut™, the world’s first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions ...

Current Opinions

The Current Opinion journals are unique, as the only journals to systematically review each life science in a series of themed issues or 'sections'. World leading scientists review their section in-depth over the last 12 months, and direct you to the most important original research


More From BioPortfolio on "Pituitary ACTH Hypersecretion Cushing Disease Pipeline Review 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks